EPISODE · Jan 26, 2022 · 7 MIN
T20K Peptide Shows Promise in MS Preclinical Studies & Managing Challenges With MS
from MS News & Perspectives · host MS News Today
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how new preclinical data continues to support the potential of Cyxone’s investigational plant-derived peptide T20K for the treatment of multiple sclerosis (MS).Price also reads the column by Jamie Hughes, A Life in Letters, “When Is a Wall Not Just a Wall?”.=================================== Are you interested in learning more about multiple sclerosis? If so, please visit:https://multiplesclerosisnewstoday.com/ =====================================To join in on conversations regarding multiple sclerosis, please visit:https://multiplesclerosisnewstoday.com/forums/
NOW PLAYING
T20K Peptide Shows Promise in MS Preclinical Studies & Managing Challenges With MS
No transcript for this episode yet
Similar Episodes
Apr 21, 2026 ·13m
Apr 19, 2026 ·16m
Apr 17, 2026 ·13m
Apr 13, 2026 ·11m
Apr 11, 2026 ·16m